Life Sciences Institute

ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19

Retrieved on: 
Monday, March 13, 2023
IC50, SARS, Heel, Research, Infection, SARS-CoV-1, Bispecific monoclonal antibody, Life Sciences Institute, Coronavirus, SARS-CoV-2, Hook effect, COVID-19, Patient, BioRxiv, Immune system, Lipid, Structural biology, Antibody, Safety, VIB, Vaccine, XBB, Immunodeficiency, Epitope

Nearly all SARS-CoV-2 neutralizing antibodies that have been used in the clinic show substantial loss of potency against currently circulating variants.

Key Points: 
  • Nearly all SARS-CoV-2 neutralizing antibodies that have been used in the clinic show substantial loss of potency against currently circulating variants.
  • It targets a conserved region in the spike S2 subunit that is essential for viral entry.
  • It neutralizes all previous and current variants of concern and the currently most frequently circulating variants, including XBB, XBB.1.5, BQ.1.1 and BF.7.
  • The pharmacodynamic and safety properties of candidate drug molecules based on these S2-binding single domain antibodies were extensively evaluated in vitro and in vivo by ExeVir Bio.

Kanazawa University research: International symposium on Nanoprobe Technology for Understanding Molecular Systems in Kanazawa, Japan

Retrieved on: 
Tuesday, November 1, 2022
Life Sciences Institute, List, Culture, School, Kanazawa University, Technology, Ministry, Student, Sea, University, Medicine, History, Humanities, Science, Sport, Education

Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology.

Key Points: 
  • Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology.
  • As the leading comprehensive university on the Sea of Japan coast, Kanazawa University has contributed greatly to higher education and academic research in Japan since it was founded in 1949.
  • The University is located on the coast of the Sea of Japan in Kanazawa a city rich in history and culture.
  • Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

Kanazawa University research: International symposium on Nanoprobe Technology for Understanding Molecular Systems in Kanazawa, Japan

Retrieved on: 
Tuesday, November 1, 2022
Life Sciences Institute, List, Culture, School, Kanazawa University, Technology, Ministry, Student, Sea, University, Medicine, History, Humanities, Science, Sport, Education

Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology.

Key Points: 
  • Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology.
  • As the leading comprehensive university on the Sea of Japan coast, Kanazawa University has contributed greatly to higher education and academic research in Japan since it was founded in 1949.
  • The University is located on the coast of the Sea of Japan in Kanazawa a city rich in history and culture.
  • Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

VIB and Surface Oncology Announce Publication in Cell Reports Revealing IL-27 Structure and the Mechanism of Action for SRF388

Retrieved on: 
Wednesday, October 19, 2022
CD73, Neoplasm, Plant, University, Novartis, Cell Reports, Engineering, Veterinary medicine, Hasselt University, Life Sciences Institute, Ghent University, Department, Inflammation Research, VIB, GLOBE, Surface, KU Leuven, FDA, IL-27, Animal, Employment, Structural biology, Research, University of Antwerp, University of Pennsylvania School of Veterinary Medicine, Unit, Inflammation, Life, Cytokine, Patient, Biotechnology, Professor, Kidney, Partnership, Orphan drug, Tumor microenvironment, PVRIG, Vrije Universiteit Brussel, GlaxoSmithKline, Â, CD39, CCR8, Liver, Fast Track, Entrepreneurship, Interleukin, Pharmaceutical industry, Coffee, Vaccine

FLANDERS, Belgium and CAMBRIDGE, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) -- VIB, Flanders’ leading life sciences institute, and Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced jointly the publication of a study entitled, “Structural basis of activation and antagonism of receptor signaling mediated by interleukin-27: Cell Reports,” in Cell Reports, a leading scientific journal. The study was a collaborative research effort between the Unit for Structural Biology at the VIB-University of Ghent Center for Inflammation Research and Surface Oncology.

Key Points: 
  • The study was a collaborative research effort between the Unit for Structural Biology at the VIB-University of Ghent Center for Inflammation Research and Surface Oncology.
  • can be found in the October 18 issue of Cell Reports [VOLUME 41, ISSUE 3, 111490, https://www.cell.com/cell-reports/fulltext/S2211-1247(22)01340-7 .
  • Furthermore, Surface Oncology has identified a potential biomarker associated with IL-27 that may be useful in helping to identify patients most likely to respond to SRF388.
  • VIB is an independent research institute where some 1,800 top scientists from Belgium and abroad conduct pioneering basic research.

Polsky Center’s DeepTechU Returns and Highlights Deep Tech Innovation in the Greater Midwest

Retrieved on: 
Friday, April 15, 2022
Semiconductor, Security, Manufacturing, Nanotechnology, Other Technology, Research, Software, Hardware, Science, Technology, Other Energy, General Health, Biotechnology, Energy, Other Manufacturing, Health, University, Education, Head, CEO, Henderson, National Science Foundation, The Great Wave off Kanagawa, University of Chicago, IBM Quantum Experience, Research, Deep tech, Organization, Life Sciences Institute, Innovation, Entrepreneurship, Industry, University, Argonne National Laboratory, Renewable energy, Management, P33

The University of Chicagos Polsky Center for Entrepreneurship and Innovation is once again hosting DeepTechU , a venture conference that brings together global investors and deep tech startups in the greater Midwest.

Key Points: 
  • The University of Chicagos Polsky Center for Entrepreneurship and Innovation is once again hosting DeepTechU , a venture conference that brings together global investors and deep tech startups in the greater Midwest.
  • Last years inaugural DeepTechU was the largest venture conference in the Midwest and demonstrated the breadth and heft of the regions deep tech community, said Jay Schrankler, associate vice president and head of the Polsky Center.
  • The Midwest is rich in deep tech innovation and talent ready for investment to leap from the lab to the market.
  • The confluence of academic, industry, and investor perspectives at DeepTechU reflects the strength of the regions growing deep tech ecosystem, Henderson said.

Kanazawa University research: 5th NanoLSI Symposium on 1-2 March 2022

Retrieved on: 
Friday, February 18, 2022
History, Technology, School, Sea, Student, Humanities, Culture, List, Ministry, Kanazawa University, University, Life Sciences Institute, Medicine, Sport, Science, Education

Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology.

Key Points: 
  • Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology.
  • As the leading comprehensive university on the Sea of Japan coast, Kanazawa University has contributed greatly to higher education and academic research in Japan since it was founded in 1949.
  • The University is located on the coast of the Sea of Japan in Kanazawa a city rich in history and culture.
  • Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

Kanazawa University research: 5th NanoLSI Symposium on 1-2 March 2022

Retrieved on: 
Friday, February 18, 2022
History, Technology, School, Sea, Student, Humanities, Culture, List, Ministry, Kanazawa University, University, Life Sciences Institute, Medicine, Sport, Science, Education

Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology.

Key Points: 
  • Nano Life Science Institute (NanoLSI), Kanazawa University is a research center established in 2017 as part of the World Premier International Research Center Initiative of the Ministry of Education, Culture, Sports, Science and Technology.
  • As the leading comprehensive university on the Sea of Japan coast, Kanazawa University has contributed greatly to higher education and academic research in Japan since it was founded in 1949.
  • The University is located on the coast of the Sea of Japan in Kanazawa a city rich in history and culture.
  • Kanazawa University is divided into two main campuses: Kakuma and Takaramachi for its approximately 10,200 students including 600 from overseas.

Stephanie Reisinger to Lead Flatiron Health’s Real-World Evidence Business

Retrieved on: 
Wednesday, January 5, 2022
General Health, Health, Oncology, Clinical Trials, Real-World Evidence, Health information management, Knowledge, Clinical trial, Life Sciences Institute, Policy, Lead, Health, Growth, Research, Patient, Hoffmann-La Roche, Business, Cancer, Data science, General manager, List of life sciences, Smeal College of Business, RWE, Senior, Genomics, RWD, Pennsylvania State University, Widener University, R, Reisinger, Leadership, Academic health science centre, Management, Allscripts, Flatiron

Flatiron Health today announced the appointment of Stephanie Reisinger as Senior Vice President and General Manager, Real-World Evidence (RWE), driving long-term strategy and growth for Flatirons RWE business unit.

Key Points: 
  • Flatiron Health today announced the appointment of Stephanie Reisinger as Senior Vice President and General Manager, Real-World Evidence (RWE), driving long-term strategy and growth for Flatirons RWE business unit.
  • Flatiron has led the field in the creation and use of RWE for oncology research and development (R&D).
  • Supported by Reisingers leadership, Flatiron will accelerate this vision to enable integrated evidence to power smarter care for every patient.
  • Prior to Flatiron, Reisinger served as the General Manager of Life Sciences Data and Analytics at Veradigm, an analytics subsidiary of Allscripts.

SkylineDx and VIB enter a strategic partnership in molecular diagnostics

Retrieved on: 
Wednesday, December 22, 2021
Physician, IVD, Disease, KU Leuven, Patient, Inflammation, CEO, Life Sciences Institute, Vrije Universiteit Brussel, University, Hasselt University, VIB, Ghent University, Research, List, Biomarker, Partnership, University of Antwerp, Medical device, Pharmaceutical industry

ROTTERDAM, Netherlands andSAN DIEGO and GHENT, Belgium, Dec. 22, 2021 /PRNewswire/ -- Today, SkylineDxannounced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics.

Key Points: 
  • ROTTERDAM, Netherlands andSAN DIEGO and GHENT, Belgium, Dec. 22, 2021 /PRNewswire/ -- Today, SkylineDxannounced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics.
  • Under the agreement, SkylineDx and VIB will jointly evaluate opportunities regarding novel molecular diagnostics, combining VIB's expertise in state-of-the-art single-cell analysis and biomarker discovery applied to molecular pathology and precision diagnostics with SkylineDx' strategic expertise, global network of renowned clinical centers and physicians, and know-how in the development, market access and early commercialization of in vitro diagnostics.
  • VIB has done cutting edge biotech discoveries and has an impressive start-up portfolio," comments Dharminder Chahal, CEO SkylineDx.
  • SkylineDx is a biotechnology company, focused on research & development of molecular diagnostics in oncology and inflammatory diseases.

SkylineDx and VIB enter a strategic partnership in molecular diagnostics

Retrieved on: 
Wednesday, December 22, 2021
Physician, IVD, Disease, KU Leuven, Patient, Inflammation, CEO, Life Sciences Institute, Vrije Universiteit Brussel, University, Hasselt University, VIB, Ghent University, Research, List, Biomarker, Partnership, University of Antwerp, Medical device, Pharmaceutical industry

ROTTERDAM, Netherlands andSAN DIEGO and GHENT, Belgium, Dec. 22, 2021 /PRNewswire/ -- Today, SkylineDxannounced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics.

Key Points: 
  • ROTTERDAM, Netherlands andSAN DIEGO and GHENT, Belgium, Dec. 22, 2021 /PRNewswire/ -- Today, SkylineDxannounced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics.
  • Under the agreement, SkylineDx and VIB will jointly evaluate opportunities regarding novel molecular diagnostics, combining VIB's expertise in state-of-the-art single-cell analysis and biomarker discovery applied to molecular pathology and precision diagnostics with SkylineDx' strategic expertise, global network of renowned clinical centers and physicians, and know-how in the development, market access and early commercialization of in vitro diagnostics.
  • VIB has done cutting edge biotech discoveries and has an impressive start-up portfolio," comments Dharminder Chahal, CEO SkylineDx.
  • SkylineDx is a biotechnology company, focused on research & development of molecular diagnostics in oncology and inflammatory diseases.